Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639782 · ClinicalTrials.gov registry record · NA
Prospective Randomized On-X Versus SJM Evaluation Trial
A NA study of Heart Valve Disease, sponsored by On-X Life Technologies.
- Completed
- Registry status
- NA
- Development phase
- 857
- Enrollment target
- 20
- Study locations
NCT00639782 is a NA study of Heart Valve Disease that has completed, run by On-X Life Technologies. The registered enrollment target is 857 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT00639782, a NA study of Heart Valve Disease, has completed, sponsored by On-X Life Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 857 participants
- Enrollment target
- 20
- Study locations
Study Summary
The study hypothesizes that rate of thromboembolic complications of the On-X prosthesis is reduced as compared to the SJM prosthesis.
Conditions Studied
Interventions
- DEVICE On-X Heart valve replacement
- DEVICE SJM Heart valve replacement
Study Locations (20)
Other
- Universitats-Herzzentrum Bad Krozingen - Freiburg im Breisgau
- Universitats-Herzzentrum Freiburg - Medical Center - Freiburg im Breisgau
- Universitats Klinik Jena - Jena
- Universitat Klinik Tübingen - Tübingen
British Columbia
- St. Paul's Hospital - Vancouver
- Vancouver General Hospital - Vancouver
- Victoria Heart Institute - Victoria
Missouri
- Washington University - St Louis - St Louis
- Christian Hospital Northeast - St Louis
California
- Southern California Permanente Medical Group - Los Angeles
Hawaii
- Kaiser Foundation Hospital - Honolulu
New Jersey
- Robert Wood Johnson Medical School - New Brunswick
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Virginia
- Sentara Norfolk General Hospital - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 857 participants |
| Start Date | 2003-07 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00639782
The ClinicalTrials.gov registry entry for NCT00639782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 857 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is On-X Life Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Valve Disease appearing as the primary indexed condition, and to 2 interventions - of which On-X Heart valve replacement is the first listed.
NCT00639782 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Other, British Columbia, Missouri.
Frequently Asked Questions
What is clinical trial NCT00639782 about?
NCT00639782 is a clinical study titled "Prospective Randomized On-X Versus SJM Evaluation Trial". The study hypothesizes that rate of thromboembolic complications of the On-X prosthesis is reduced as compared to the SJM prosthesis.
What is the current status of trial NCT00639782?
This trial is currently completed. It is a NA study. The enrollment target is 857 participants. The study started on 2003-07. Estimated completion is 2021-05-01.
What conditions does trial NCT00639782 study?
This clinical trial studies the following conditions: Heart Valve Disease.
What interventions are being tested in trial NCT00639782?
The interventions under investigation include: On-X Heart valve replacement (DEVICE), SJM Heart valve replacement (DEVICE).
Who is sponsoring clinical trial NCT00639782?
This trial is sponsored by On-X Life Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00639782 being conducted?
This trial has 20 study locations across California, Hawaii, Missouri, New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.